Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery

BackgroundObesity is a multifactorial disease, which is strongly associated to other metabolic disorders. Bariatric surgery is the most effective treatment of morbid obesity. The role of beta cell function in weight loss after bariatric surgery is uncertain.AimTo evaluate the association between bet...

Full description

Bibliographic Details
Main Authors: Marta Borges-Canha, João Sérgio Neves, Fernando Mendonça, Maria Manuel Silva, Cláudia Costa, Pedro M. Cabral, Vanessa Guerreiro, Rita Lourenço, Patrícia Meira, Daniela Salazar, Maria João Ferreira, Jorge Pedro, Ebrahim Barkoudah, Ana Sande, Eva Lau, Selma B. Souto, John Preto, Paula Freitas, Davide Carvalho
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.714173/full
id doaj-e989f6eb6870429f9ae388d2b3fa4e17
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Marta Borges-Canha
Marta Borges-Canha
João Sérgio Neves
João Sérgio Neves
Fernando Mendonça
Maria Manuel Silva
Cláudia Costa
Pedro M. Cabral
Vanessa Guerreiro
Rita Lourenço
Patrícia Meira
Daniela Salazar
Maria João Ferreira
Jorge Pedro
Ebrahim Barkoudah
Ana Sande
Eva Lau
Selma B. Souto
John Preto
Paula Freitas
Paula Freitas
Davide Carvalho
Davide Carvalho
spellingShingle Marta Borges-Canha
Marta Borges-Canha
João Sérgio Neves
João Sérgio Neves
Fernando Mendonça
Maria Manuel Silva
Cláudia Costa
Pedro M. Cabral
Vanessa Guerreiro
Rita Lourenço
Patrícia Meira
Daniela Salazar
Maria João Ferreira
Jorge Pedro
Ebrahim Barkoudah
Ana Sande
Eva Lau
Selma B. Souto
John Preto
Paula Freitas
Paula Freitas
Davide Carvalho
Davide Carvalho
Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery
Frontiers in Endocrinology
beta cell function
insulin resistance
bariatric surgery
morbid obesity
weight loss
author_facet Marta Borges-Canha
Marta Borges-Canha
João Sérgio Neves
João Sérgio Neves
Fernando Mendonça
Maria Manuel Silva
Cláudia Costa
Pedro M. Cabral
Vanessa Guerreiro
Rita Lourenço
Patrícia Meira
Daniela Salazar
Maria João Ferreira
Jorge Pedro
Ebrahim Barkoudah
Ana Sande
Eva Lau
Selma B. Souto
John Preto
Paula Freitas
Paula Freitas
Davide Carvalho
Davide Carvalho
author_sort Marta Borges-Canha
title Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery
title_short Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery
title_full Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery
title_fullStr Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery
title_full_unstemmed Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery
title_sort beta cell function as a baseline predictor of weight loss after bariatric surgery
publisher Frontiers Media S.A.
series Frontiers in Endocrinology
issn 1664-2392
publishDate 2021-08-01
description BackgroundObesity is a multifactorial disease, which is strongly associated to other metabolic disorders. Bariatric surgery is the most effective treatment of morbid obesity. The role of beta cell function in weight loss after bariatric surgery is uncertain.AimTo evaluate the association between beta cell function and percentage of total body weight loss (TBWL%) 1, 2, 3, and 4 years after bariatric surgery in patients with morbid obesity.MethodsRetrospective longitudinal study in patients with morbid obesity followed in our center between January 2010 and July 2018. Patients were excluded if they had diabetes at baseline or missing data on the needed parameters. We evaluated baseline Homeostatic Model Assessment of IR, Homeostatic Model Assessment of β-cell function (HOMA-beta), Quantitative Insulin Sensitivity Check Index, and Matsuda and DeFronzo index, and TBWL% at years 1 to 4. Linear regression models were used to evaluate the association of indexes of insulin resistance with TBWL% (unadjusted and adjusted for age, sex, BMI, and type of surgery).ResultsThere were 1,561 patients included in this analysis. HOMA-beta was negatively associated with TBWL% at second, third, and fourth years post-surgery (β = −1.04 [−1.82 to −0.26], p<0.01; β = −1.16 [−2.13 to −0.19], p=0.02; β = −1.29 [−2.64 to 0.06], p=0.061, respectively). This was not observed in the first year post-surgery nor for the other indexes. Glycemia at baseline was positively associated to EWL% at second and third years post-surgery.Conclusionβ-cell function at baseline seems to be associated to long-term weight loss, explicitly after the first year post bariatric surgery. This might be a helpful predictor of weight loss in clinical practice.
topic beta cell function
insulin resistance
bariatric surgery
morbid obesity
weight loss
url https://www.frontiersin.org/articles/10.3389/fendo.2021.714173/full
work_keys_str_mv AT martaborgescanha betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT martaborgescanha betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT joaosergioneves betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT joaosergioneves betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT fernandomendonca betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT mariamanuelsilva betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT claudiacosta betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT pedromcabral betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT vanessaguerreiro betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT ritalourenco betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT patriciameira betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT danielasalazar betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT mariajoaoferreira betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT jorgepedro betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT ebrahimbarkoudah betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT anasande betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT evalau betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT selmabsouto betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT johnpreto betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT paulafreitas betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT paulafreitas betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT davidecarvalho betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
AT davidecarvalho betacellfunctionasabaselinepredictorofweightlossafterbariatricsurgery
_version_ 1721209820149710848
spelling doaj-e989f6eb6870429f9ae388d2b3fa4e172021-08-12T04:48:12ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-08-011210.3389/fendo.2021.714173714173Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric SurgeryMarta Borges-Canha0Marta Borges-Canha1João Sérgio Neves2João Sérgio Neves3Fernando Mendonça4Maria Manuel Silva5Cláudia Costa6Pedro M. Cabral7Vanessa Guerreiro8Rita Lourenço9Patrícia Meira10Daniela Salazar11Maria João Ferreira12Jorge Pedro13Ebrahim Barkoudah14Ana Sande15Eva Lau16Selma B. Souto17John Preto18Paula Freitas19Paula Freitas20Davide Carvalho21Davide Carvalho22Serviço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalDepartamento de Cirurgia e Fisiologia, Faculdade de Medicina da Universidade do Porto, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalDepartamento de Cirurgia e Fisiologia, Faculdade de Medicina da Universidade do Porto, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Endocrinologia do Instituto Português de Oncologia do Porto, Francisco Gentil, EPE, Porto, PortugalServiço de Patologia Clínica do Centro Hospitalar Universitário Cova da Beira, EPE, Covilhã, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalFaculdade de Ciências da Nutrição e Alimentação da Universidade do Porto, Porto, PortugalFaculdade de Ciências da Nutrição e Alimentação da Universidade do Porto, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalDepartment of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, United StatesServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Cirurgia Geral do Centro Hospitalar Universitário de São João, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalInvestigação e Inovação em Saúde (i3s), Faculdade de Medicina da Universidade do Porto, Porto, PortugalServiço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário de São João, Porto, PortugalInvestigação e Inovação em Saúde (i3s), Faculdade de Medicina da Universidade do Porto, Porto, PortugalBackgroundObesity is a multifactorial disease, which is strongly associated to other metabolic disorders. Bariatric surgery is the most effective treatment of morbid obesity. The role of beta cell function in weight loss after bariatric surgery is uncertain.AimTo evaluate the association between beta cell function and percentage of total body weight loss (TBWL%) 1, 2, 3, and 4 years after bariatric surgery in patients with morbid obesity.MethodsRetrospective longitudinal study in patients with morbid obesity followed in our center between January 2010 and July 2018. Patients were excluded if they had diabetes at baseline or missing data on the needed parameters. We evaluated baseline Homeostatic Model Assessment of IR, Homeostatic Model Assessment of β-cell function (HOMA-beta), Quantitative Insulin Sensitivity Check Index, and Matsuda and DeFronzo index, and TBWL% at years 1 to 4. Linear regression models were used to evaluate the association of indexes of insulin resistance with TBWL% (unadjusted and adjusted for age, sex, BMI, and type of surgery).ResultsThere were 1,561 patients included in this analysis. HOMA-beta was negatively associated with TBWL% at second, third, and fourth years post-surgery (β = −1.04 [−1.82 to −0.26], p<0.01; β = −1.16 [−2.13 to −0.19], p=0.02; β = −1.29 [−2.64 to 0.06], p=0.061, respectively). This was not observed in the first year post-surgery nor for the other indexes. Glycemia at baseline was positively associated to EWL% at second and third years post-surgery.Conclusionβ-cell function at baseline seems to be associated to long-term weight loss, explicitly after the first year post bariatric surgery. This might be a helpful predictor of weight loss in clinical practice.https://www.frontiersin.org/articles/10.3389/fendo.2021.714173/fullbeta cell functioninsulin resistancebariatric surgerymorbid obesityweight loss